Distinguished Speakers

OCASCR invites multiple Distinguished Speakers to visit Oklahoma each year and to share their adult stem cell or regenerative medicine research with local scientists through a seminar series. This provides an important opportunity for Oklahoma scientists to stay abreast of cutting edge research and to broaden their scientific network through individual meetings with the Distinguished Speakers. Past seminars that were sponsored by OCASCR included:

  • Development of stem cell therapy for the treatment of retinal degeneration.
    Robin Ali, PhD, FMedSci
    The Biomedical Research Centre for Ophthalmology
    London, England
  • Small Blood Vessels- Big Secrets
    Christer Betsholtz, Ph.D.
    Stockholm, Sweden
  • Regulating Hematopoietic Stem Cells for Enhance Function and Engraftment
    Hal E. Broxmeyer, Ph.D.
    Indiana University
    Indianapolis, Indiana
  • Engineering Adult Stem Cell Microenvironments for Tissue Repair
    Jason Burdick, Ph.D.
    University of Pennsylvania
    Philadelphia, PA
  • Toward unification of the Cancer Stem Cell and Clonal Evolution Models of Cancer
    John E. Dick, Ph.D.
    Ontario Cancer Institute Toronto
    Ontario, Canada
  • Regulation of Cell Turnover During Epithelial Tissue Homeostasis and Pathogenesis
    George Eisenhoffer, Ph.D.
    MD Anderson Cancer Center
    Houston, TX
  • Hematopoietic Stem Cell Microenvironment
    Paul S.Frenette, M.D.
    Ruth L. And David S. Gottesman Institute for Stem Cell Regenerative
    Medicine Research
    Albert Einstein College of Medicine
    Bronx, New York
  • Stem Cells in Silence, Action and Cancer
    Elaine Fuchs, Ph.D.
    The Rockefeller University
    New York, New York
  • Flow Dependent Endothelial Cell (Dys)Function
    Guillermo García-Cardeña, Ph.D.
    Harvard Medical School
    Boston, Massachusetts
  • Stem Cells in the Fight Against Alzheimer’s Disease
    Lawrence S.B. Goldstein, Ph.D.
    University of California
    San Diego, CA
  • Adult Stem Cell Research Workshop
    Jeffrey Gimble, M.D., Ph.D.
    Pennington Biomedical Research Center
    Baton Rouge, Louisiana
  • Transcriptional Heterogeneity and Stem Cell Therapeutics
    Geoffrey C. Gurtner, MD
    Stanford University of Medicine
    Palo Alto, Calilfornia
  • Lung Stem Cells and Homeostasis and Repair
    Brigid L. M. Hogan, Ph.D., FRS
    Duke University
    Durham, North Carolina
  • Microbiome Interactions with the Nervous System in Health and Disease
    Elain Y. Hsiao, Ph.D.
    University of California, Los Angeles
    Los Angeles, California
  • Age-related Stem cell Dysfunction in Barrier Epithelia- Strategies for Intervention
    Heinrich Jasper, Ph.D.
    Genentech Inc.
    San Francisco, California
  • Modeling Human Development and Disease with Pluripotent Stem Cells
    Gordon M Keller, Ph.D.
    University of Toronto
    Toronto, Canada
  • Stem Cells and Nanotechnology for Neurological Therapeutics
    John A. Kessler, M.D.
    Feinberg Neuroscience Institute
    Northwestern University Feinberg School of Medicine Stem Cell Institute
    Chicago, Illinois
  • Mechanobiological regulation of normal and tumor stem cells
    Sanjay Kumar,MD, Ph.D.
    University of California
    Berkeley, California
  • Skelatal Stem Cells
    Michael Longaker, MD, MBA,D.Sc.(Hon). FACS
    Stanford University
    Stanford, California
  • Autologous CD34 Cell Therapy for Myocardial and Lower Extremity Ischemia
    Douglas W. Losordo, MD
    Feinberg Cardiovascular Research Institute
    Northwestern University’s Feinberg School of Medicine
    Chicago, Illinois
  • Mesenchymal Stromal (Stem) Cells: Biology and Potential Therapeutic Value for the Acute Respiratory Distress Syndrome
    Michael Matthay, MD
    University of California
    San Francisco, California
  • Generation and Repair of Nephrons
    Andrew P. McMahon, Ph.D.
    University of Southern California
    Los Angeles, California
  • Proteostatic control of quiescence exit in mammalian neural stem cells
    Darcie Moore, Ph.D.
    University of Wisconsin-Madison
    Madison, Wisconsin
  • Stem Cell Niches for Hematopoiesis and Osteogenesis
    Sean Morrison, Ph.D.
    University of Texas Southwestern
    Dallas, Texas
  • Non-myelinating Schwann cells in the mouse bone marrow niche maintain hematopoietic stem cell hibernation through TGF-b signaling
    Hiromitsu Nakauchi, MD
    Division of Stem Cell Therapy,
    Center for Stem Cell Biology and Medicine,
    Institute of Medical Science,
    University of Tokyo, Japan.
    Japan Science and Technology Agency (JST), ERATO
    Nakauchi Stem Cell and Organ Regeneration Project
  • Personalized Medicine in Cystic Fibrosis
    Anjaparavanda P. Naren, Ph.D.
    Cincinnati Children’s Hospital Medical Center
    Cincinnati, Ohio
  • Dissecting Developmental Trajectories with Single-Cell Transcriptional Profiling
    Craig E. Nelson, Ph.D.
    University of Connecticut
    Storrs, Connecticut
  • Strategies for Extramural Funding
    Michael Nunn, Ph.D.
    Salk Institute for Biological Studies
    La Jolla, CA
  • Network and Space Models: Science and Science Fiction Approaches to Cell Fate Prediction
    John Quackenbush
    Dana Farber Cancer Institute and Harvard School of Public Health
    Boston, Massachusetts
  • Aging, Stem Cells, and Tissue Regeneration
    Tom Rando, Ph.D.
    Stanford University
    Stanford, California
  • Skeletal Stem Cells: History, Origins and Function
    Pamela Gehron Robey, Ph.D.
    National Institutes of Health
    Bethesda, Maryland
  • Fate Mapping of Hematopoietic Stem Cell Activity In Vivo
    Hans-Reimer Rodewald, Ph.D.
    German Cancer Research Center
    Heidelberg, Germany
  • Niche Oncogenesis
    David T. Scadden, MD
    Harvard University Cambridge, Massachusetts
  • Adult Stem Cells, Matrix Scaffolds and Bioreactors for Cardiac Valve Tissue Regeneration
    Dan Simionescu, Ph.D.
    Clemson University
    Clemson, SC
  • Deconstructing the Face, One Phosphate at a Time.
    Phillipe Soriano, Ph.D.
    Icahn School of Medicine at Mount Sinai
    New York City, NY
  • CSF-1 receptor signaling and biology and their relevance to neoplastic, inflammatory and neurodegenerative diseases
    Richard Stanley. Ph.D.
    Albert Einstein College of Medicine
    New York, New York
  • Development of Hematopoietic Stem Cells
    David Traver, Ph.D.
    University of California, San Diego
    La Jolla, California
  • Regenerative Medicine Meets Chemical Genomics; Novel Approaches to Novel Therapeutics Discovery
    Weidong Wang, Ph.D.
    iPerian, Inc.
    San Francisco, California
  • Prostate Tissue Stem Cells and Prostate Cancer
    Owen Witte, MD
    Howard Hughes Medical Institute
    UCLA
    Los Angeles, California
  • Stem Cells: Niche, Competition Aging and Potential Application
    Ting Xie, Ph.D.
    Stowers Institute for Medical Research
    Kansas City, Missouri
  • Isolating and Defining Cells to Engineer Human Vessels for Vascular
    Repair
    Mervin C. Yoder, M.D.
    Herman B Wells center for Pediatric Research
    Indianapolis, Indiana
  • ITIM- Receptor’s Surprising Roles in Hematopoietic and Leukemia
    Stem Cells
    Chengchen (Alec) Zhang, Ph.D.
    University of Texas Southwestern
    Dallas, Texas